Highlights of AAN 2010
Toronto, Ontario, Canada
April 10–17, 2010
HIGHLIGHTS DAILY COVERAGE
This issue of Neura Special Report features highlights from the 62nd Annual Meeting of the American Academy of Neurology (AAN).
Download the Full Coverage
- An overview of several studies investigating lithium carbonate as a potential treatment for ALS.
- A review of Medicare records leads to new findings on healthcare costs and co-morbidities among Alzheimer’s patients.
- New findings concerning the progression and patterns of care in Parkinson’s disease.
- A study noting increased incidence of headache in a population with multiple sclerosis (MS).
- Several analyses of the effects of disease-modifying therapies (DMTs) on patients’ clinical and economic outcomes.
- Updates and new data on studies involving several oral therapies under investigation, including oral teriflunomide and laquinimod.
- Data reveal that vitamin D levels are low compared to controls in both MS patients and the elderly.
- Reports on the increase of mortality and hospital costs related to traumatic brain injury (TBI).
GUEST EDITORS:
Edward J. Fox, MD, PhD
Director, MS Clinic of Central Texas
Clinical Assistant Professor
University of Texas Medical Branch
Round Rock, Texas
Patricia K. Coyle, MD
Professor and Acting Chair of Neurology
Director, Stony Brook MS Comprehensive Care Center
Department of Neurology
Stony Brook University Medical Center
Stony Brook, New York
Neura On-Site coverage of the 62nd Annual Meeting of the American Academy of Neurology (AAN) held in Toronto, Ontario, Canada, includes a summary of select presentations presented during the meeting.
